Finance

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE

SUZHOU, China, and ROCKVILLE, Md., June 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for...

Jio Fin, Adani Green, Zomato among cos eligible for F&O

With the proposed changes in criteria for stocks to be eligible for the futures and options segment, around 25 stocks are likely to...

Asia stocks range-bound as EU politics adds new risks By Reuters

By Wayne Cole SYDNEY (Reuters) - Asian stocks traded in a narrow range on Tuesday, as investors pondered fresh political uncertainty in...

IndiGo promoter Bhatia family may sell 2% for $394 million

The Bhatia family, promoters of India's largest airline IndiGo, is likely to to sell a 2% stake in the company on Tuesday for...

Target Hospitality Provides Update on South Texas Family Residential Center Located in Dilley Texas By Investing.com

THE WOODLANDS, Texas, June 10, 2024 /PRNewswire/ --  Target Hospitality Corp. ("Target Hospitality (NASDAQ:)", "Target" or the "Company") (NASDAQ: TH), one of North...

Angry scenes as Israeli parliament votes on conscription law

JERUSALEM: Israel's parliament moved ahead with a contentious law on conscripting ultra-Orthodox religious students into the military amid angry scenes on Monday in...

Four American educators stabbed in park in northeast China, says US media and officials By Reuters

BEIJING (Reuters) - Four American educators from a small Iowa university were reportedly stabbed in a public park in northeast China's Jilin...

Fertiliser, agrochemical stocks rally as monsoon arrives early

Shares of fertiliser and agrochemical companies were among the top gainers on the BSE on Monday, after monsoons progressed earlier than expected in...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that on June 10, 2024, the Compensation Committee of Mirum's Board of...

Latest articles

spot_imgspot_img